210
Participants
Start Date
November 30, 2000
Abacavir sulfate
Nelfinavir mesylate
Lamivudine
GW433908
Gervais Frechette, New York
Howard Grossman, New York
Mount Sinai School of Medicine, New York
Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx
Addiction Research and Treatment Corp, Brooklyn
Univ of Rochester Med Ctr, Rochester
Thomas Jefferson Univ, Philadelphia
SMO-USA Inc, Charlotte
Florida ID Group, Orlando
Hillsborough County Health Dept, Tampa
Clinical Pharmacology Services, Tampa
Veterans Affairs Med Ctr of North Chicago, Chicago
Walter Gaman, Irving
MacGregor Med Association, Houston
Southwest Texas Methodist Hosp, San Antonio
Ocean View Internal Medicine, Long Beach
East Bay Clinical Trial Ctr, Concord
Advanced Clinical Trials Inc, Eugene
Brookdale Univ Hosp and Med Ctr, Brooklyn
Univ of Kansas Med Ctr, Kansas City
Univ of Texas Med Branch, Galveston
Saint Michael's Med Ctr, Newark
UMDNJ - New Jersey Med School, Newark
Lead Sponsor
Glaxo Wellcome
INDUSTRY